Primers used in this study
| Target mRNA | Forward primer(5’−3’) | Reverse primer (5’−3’) |
| Human | ||
| GAPDH | GAAGGTGAAGGTCGGAGTC | GAAGATGGTGATGGGATTT |
| TNFA | GGCTCCAGGCGGTGCTTG | CAGATAGATGGGCTCATACCA |
| ARG-1 | GCAGAAGTCAAGAAGAACGG | GGTTGTCAGTGGAGTGTTG |
| VEGF | TGCATT CACATTTGTTGTGC | AGACCCTGGTGGACATCTTC |
| CD206 | GAGCAAACATACCTGACAGGATTA | GGACTTCCTGGTAACCAGTTCA |
| Mouse | ||
| GAPDH | GTGCTGAGTATGTCGTGGAGTCTAC | TTGCTGACAATCTTGAGTGAGTTG |
| ARG-1 | GAACACGGCAGTGGCTTTAAC | TGCTTAGCTCTGTCTGCTTTGC |
| VEGF | AGTCCCATGAAGTGATAAGTTCA | ATCCGCATGATCTGCATGG |
| GZMB | TCCTGCTACTGCTGACCTTGTC | CTTGATCGAAAGTAAGGCCATGT |
| iNOS | CAGCTGGGCTGTACAAACCTT | CATTGGAAGTGAAGCGGTTCG |
ARG-1, arginase-1; TNFA, tumor necrosis factor alpha; VEGF, vascular endothelial growth factor.